Researcher
Cara De Galan
- Disciplines:Inflammation, Gastro-enterology
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → 24 Sep 2023 - Department of Internal medicine (Department)
Member
From1 Mar 2017 → 30 Sep 2018 - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Oct 2016 → 30 Sep 2017
Publications
1 - 10 of 10
- Role of integrin expression in the prediction of response to vedolizumab : a prospective real‐life multicentre cohort study(2022)
Authors: Cara De Galan, Sophie Van Welden, Triana Lobatón Ortega, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Debby Laukens
- The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients : a real-life multicentre cohort study(2022)
Authors: Cara De Galan, Marie Truyens, Harald Peeters, Francisco Mesonero Gismero, Ainara Elorza, Paola Torres, Liv Vandermeulen, Aranzazu Jauregui Amezaga, Rocio Ferreiro- Iglesias, Tom Holvoet, et al.
Pages: 1676 - 1686 - The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients : a real-life multicentric cohort study(2021)Volume: 15
Authors: Marie Truyens, Cara De Galan, H Peeters, F Mesonero Gismero, A Elorza, P Torres, L Vandermeulen, A Jauregui Amezaga, R Ferreiro-Iglesias, T Holvoet, et al.
Pages: S302 - S302 - Long-term environmental hypoxia exposure and haematopoietic prolyl hydroxylase-1 deletion do not impact experimental Crohn's like ileitis(2021)
Authors: Cara De Galan, Debby Laukens, Sophie Van Welden
- Safety of vedolizumab and ustekinumab in elderly IBD patients : a real-life multicentric cohort study(2021)Volume: 9
Authors: Cara De Galan, Marie Truyens, Harald Peeters, Francisco Mesonero Gismero, Ainara Elorza, Paola Torres, Liv Vandermeulen, Aranzazu Jauregui Amezaga, Rocio Ferreiro-Iglesias, Tom Holvoet, et al.
Pages: 554 - 555 - Long-term environmental hypoxia does not impact experimental Crohn's like ileitis(2021)
Authors: Cara De Galan, Sophie Van Welden, Triana Lobatón Ortega, Pieter Hindryckx, Martine De Vos, Debby Laukens
Number of pages: 1 - Early prediction of response to vedolizumab in patients with active inflammatory bowel disease : a prospective real-life multicentre cohort study(2021)
Authors: Cara De Galan, Gerard Bryan Gonzales, Sophie Van Welden, Simon Tavernier, Triana Lobatón Ortega, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Martine De Vos, et al.
Number of pages: 1 - Integrin expression changes on the T cells subsets influence the response to vedolizumab in inflammatory bowel disease patients(2020)
Authors: Cara De Galan, Sophie Van Welden, Simon Bos, Triana Lobatón Ortega, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Debby Laukens
Number of pages: 1 - Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients(2019)
Authors: Cara De Galan, Sophie Van Welden, Simon Bos, Triana Lobatón Ortega, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Debby Laukens
Number of pages: 1 - New insights in the use of vedolizumab in inflammatory bowel disease
Authors: Cara De Galan